• 749 Citations
  • 13 h-Index
20002017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yali He is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Androgen Receptors Medicine & Life Sciences
Anabolic Agents Medicine & Life Sciences
Androgens Medicine & Life Sciences
Glucocorticoid Receptors Medicine & Life Sciences
Ligands Medicine & Life Sciences
Glucocorticoids Medicine & Life Sciences
Non-Steroidal Estrogens Medicine & Life Sciences
Toremifene Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2017

  • 749 Citations
  • 13 h-Index
  • 10 Article
  • 5 Review article
  • 1 Chapter
5 Citations (Scopus)

Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer

Ponnusamy, S., Coss, C. C., Thiyagarajan, T., Watts, K., Hwang, D. J., He, Y., Selth, L. A., McEwan, I. J., Duke, C. B., Pagadala, J., Singh, G., Wake, R., Ledbetter, C., Tilley, W. D., Moldoveanu, T., Dalton, J. T., Miller, D. & Narayanan, R., Nov 15 2017, In : Cancer Research. 77, 22, p. 6282-6298 17 p.

Research output: Contribution to journalArticle

Castration
Androgen Receptors
Prostatic Neoplasms
Protein Isoforms
Androgen Receptor Antagonists
17 Citations (Scopus)

Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation

Narayanan, R., Yepuru, M., Coss, C. C., Wu, Z., Bauler, M. N., Barrett, C. M., Mohler, M. L., Wang, Y., Kim, J., Snyder, L. M., He, Y., Levy, N., Miller, D. & Dalton, J. T., Dec 26 2013, In : PLoS One. 8, 12, 0083380.

Research output: Contribution to journalArticle

Receptor Protein-Tyrosine Kinases
Protein-Tyrosine Kinases
tyrosine
phosphotransferases (kinases)
inflammation
9 Citations (Scopus)

Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen

Kim, J., Coss, C. C., Barrett, C. M., Mohler, M. L., Bohl, C. E., Li, C. M., He, Y., Veverka, K. A. & Dalton, J. T., Mar 15 2013, In : International Journal of Cancer. 132, 6, p. 1475-1485 11 p.

Research output: Contribution to journalArticle

Toremifene
Tamoxifen
Cytochrome P-450 Enzyme System
Breast Neoplasms
Estrogen Receptors
18 Citations (Scopus)

Estrogen receptor β selective nonsteroidal estrogens: Seeking clinical indications

Mohler, M. L., Narayanan, R., Coss, C. C., Hu, K., He, Y., Wu, Z., Hong, S. S., Hwang, D. J., Miller, D. & Dalton, J. T., Apr 1 2010, In : Expert Opinion on Therapeutic Patents. 20, 4, p. 507-534 28 p.

Research output: Contribution to journalReview article

Non-Steroidal Estrogens
Estrogen Receptors
Estrogens
Literature
Selective Estrogen Receptor Modulators
15 Citations (Scopus)

Nonsteroidal selective androgen receptor modulators enhance female sexual motivation

Jones, A., Hwang, D. J., Duke, C. B., He, Y., Siddam, A., Miller, D. & Dalton, J. T., Aug 1 2010, In : Journal of Pharmacology and Experimental Therapeutics. 334, 2, p. 439-448 10 p.

Research output: Contribution to journalArticle

Androgen Receptors
Motivation
Muscles
Prostate
1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline